fosaprepitant
- Product NDC
- 70710-1615
- 11-digit product format
- 707101615
- Labeler code
- 70710
- Product ID
- 70710-1615_581a51f5-a274-42ed-aa14-851067573d1a
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- fosaprepitant
- Dosage form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS
- Labeler
- Zydus Pharmaceuticals USA Inc.
- Application
- ANDA212957
- Marketing category
- ANDA
- Marketing start
- 2020-11-01
- Marketing end
- 0000-00-00
- Substance
- FOSAPREPITANT
- Active strength
- 150 mg/5mL
- Pharmacologic classes
- Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Neurokinin 1 Antagonists [MoA], Substance P/Neurokinin-1 Receptor Antagonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70710-1615-1 | 70710161501 | 1 VIAL in 1 CARTON (70710-1615-1) > 5 mL in 1 VIAL | 1 vial | 2020-11-01 | 0000-00-00 | No | No | Current |